Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect mixed but generally supportive reactions to the study, with references to past influential trials like ProCESS and the broad implications for sepsis management. Words such as 'changed how we looked at EGDT' and questions like 'Is this the end of early goal-directed therapy' demonstrate a tone of reevaluation and potential paradigm shifts, signifying moderate engagement and recognition of clinical impact.
Most discussions acknowledge that the study challenges the effectiveness of EGDT, indicating moderate agreement on its findings.
The topic appears to generate moderate curiosity, especially given the historical significance of earlier studies like ProCESS.
Participants reference multiple studies, data points, and implications, showing a balanced engagement with the research.
The discussions imply that the trial could influence clinical practice and future research directions, signifying a notable but not definitive impact.
Back in the previous decade I quite enjoyed the ProCESS study, which was one of three to overturn EGDT/Rivers. It used clinician judgement and the "shock index" (HR/SBP) rather than other measurements to determine circulatory management. https://t.co/YqkNZesRQj @NEJM
Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients No changes in mortality Specifically, worse kidney function in group that received high fluid volumes #meded #FOAmed https://t.co/Go7usLOYNE
Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic available here: https://t.co/AvpxZAqo8q Original paper: https://t.co/DvrMiUxwlY https://t.co/MaRBpMfZiJ
The Process trial changed how we looked at EGDT in #sepsis. https://t.co/uDeukJcA3i #chestchat
Sepsis/septic shock: ( EGDT “Rivers”, ProCESS, ARISE, ProMISe, ADRENAL, VASST, ATHOS-3, ANDROMEDA-Shock, APROCCHSS, VITAMINS) https://t.co/TGShbtW2M2 https://t.co/lLoPnCCql5 https://t.co/GKZ0bwEeNJ https://t.co/kMdsFMAjcv https://t.co/RhXliqKHJt https://t.co/2qf8ROLRRQ
Dr. Kellum's number one most cited article of the decade deals with Sepsis! Remind yourself what this article from 2014 with over 2,000 citations has to say about "A randomized trial of protocol-based care for early septic shock" https://t.co/stkf98w3xn
This educational video reviews the current state of septic shock management, emphasizing recent clinical trials comparing early goal-directed therapy with standard care and its impact on patient survival and organ…
This episode discusses critical care advancements, focusing on early goal-directed therapy, fluid responsiveness, oxygen delivery, and integrating data points for patient management. Highlights include recent trials and…
PROCESS trial https://t.co/ROlq1Wjv4Z
A Randomized Trial of Protocol-Based Care for Early Septic Shock https://t.co/WywoToPfDt
@CynWilliams3 @BKetabchi @SuttonScience @DrJaimeFriedman https://t.co/ZNlsNfiw20
RT @jfdwolff: Back in the previous decade I quite enjoyed the ProCESS study, which was one of three to overturn EGDT/Rivers. It used clinic…
RT @jfdwolff: Back in the previous decade I quite enjoyed the ProCESS study, which was one of three to overturn EGDT/Rivers. It used clinic…
RT @jfdwolff: Back in the previous decade I quite enjoyed the ProCESS study, which was one of three to overturn EGDT/Rivers. It used clinic…
Back in the previous decade I quite enjoyed the ProCESS study, which was one of three to overturn EGDT/Rivers. It used clinician judgement and the "shock index" (HR/SBP) rather than other measurements to determine circulatory management. https://t.co/YqkNZesRQj @NEJM
RT @CCCNPitt: Dr. Kellum's number one most cited article of the decade deals with Sepsis! Remind yourself what this article from 2014 with…
Dr. Kellum's number one most cited article of the decade deals with Sepsis! Remind yourself what this article from 2014 with over 2,000 citations has to say about "A randomized trial of protocol-based care for early septic shock" https://t.co/stkf98w3xn
RT @SamaherHashim: Sepsis/septic shock: ( EGDT “Rivers”, ProCESS, ARISE, ProMISe, ADRENAL, VASST, ATHOS-3, ANDROMEDA-Shock, APROCCHSS, VITA…
RT @SamaherHashim: Sepsis/septic shock: ( EGDT “Rivers”, ProCESS, ARISE, ProMISe, ADRENAL, VASST, ATHOS-3, ANDROMEDA-Shock, APROCCHSS, VITA…
Sepsis/septic shock: ( EGDT “Rivers”, ProCESS, ARISE, ProMISe, ADRENAL, VASST, ATHOS-3, ANDROMEDA-Shock, APROCCHSS, VITAMINS) https://t.co/TGShbtW2M2 https://t.co/lLoPnCCql5 https://t.co/GKZ0bwEeNJ https://t.co/kMdsFMAjcv https://t.co/RhXliqKHJt https://t.co/2qf8ROLRRQ
RT @CCCNPitt: Is protocol-based resuscitation superior to usual care with sepsis? Find out in this multi-center trial comparing alternative…
Is protocol-based resuscitation superior to usual care with sepsis? Find out in this multi-center trial comparing alternative resuscitation strategies in a broad cohort of patients with septic shock #AKI https://t.co/504QIMPo3S
RT @drkt: and b/c i'll be tied up for the next little bit: let's take a look at the PROCESS trial on sepsis bundles. #CCMJC #COVID19 #surgi…
and b/c i'll be tied up for the next little bit: let's take a look at the PROCESS trial on sepsis bundles. #CCMJC #COVID19 #surgicalcriticalcare #SoMe4Surgery #SoMe4CriticalCare #critcaremed #CriticalCare #CriticalCareMedicine #surgicaleducation https://t.co/ohdimfK2Lj
A Randomized Trial of Protocol-Based Care for Early Septic Shock | NEJM https://t.co/OGQKhPqaQG
RT @Caduceusblogger: The Process trial changed how we looked at EGDT in #sepsis. https://t.co/uDeukJcA3i #chestchat
RT @Caduceusblogger: The Process trial changed how we looked at EGDT in #sepsis. https://t.co/uDeukJcA3i #chestchat
The Process trial changed how we looked at EGDT in #sepsis. https://t.co/uDeukJcA3i #chestchat
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
RT @WeAreCanadiEM: Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic…
Check out the new #MVPInfographic detailing the 2014 ProCESS trial from @NEJM ! @AnsonDinh @AylC1989 Full infographic available here: https://t.co/AvpxZAqo8q Original paper: https://t.co/DvrMiUxwlY https://t.co/MaRBpMfZiJ
RT @nephondemand: Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients…
RT @nephondemand: Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients…
RT @nephondemand: Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients…
RT @nephondemand: Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients…
RT @nephondemand: Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients…
RT @nephondemand: Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients…
Trials in AKI: Tweet Summaries • ProCESS https://t.co/g7YQSkHOnn Comparing 3 forms of fluid therapy for septic patients No changes in mortality Specifically, worse kidney function in group that received high fluid volumes #meded #FOAmed https://t.co/Go7usLOYNE
RT @1stJohnnyMac: @dr_doddle @ketaminh It seems to be open access on the nejm site. https://t.co/risaaoc6yY
@dr_doddle @ketaminh It seems to be open access on the nejm site. https://t.co/risaaoc6yY
“@Skepticscalpel: NEJM: Is this the end of early goal-directed therapy for sepsis? http://www.nejm.org/doi/full/10.1056/NEJMoa1401602?query=OF” OMG!
The impact of serial use of PCT* was demonstrated in a health economic model that compared procalcitonin-aided antibiotic stewardship vs. usual care for ...
doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18. PMID: 24635773. Source: NIH HealthPro offers custom classes to meet your needs. Give us a call at 951-279-6110 ...
A randomized trial of protocol-based care for early septic shock. N. Engl J Med. 2014; 370(18): 1683–1693, doi: 10.1056/NEJMoa1401602, indexed in Pubmed: ...
A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-1693. doi: 10.1056/nejmoa1401602. 59. ARISE Investigators; ANZICS ...
10.1056/NEJMoa1401602 Abstract http://www.nejm.org/doi/full/10.1056/NEJMoa140. 1602. 3. The ARISE Investigators and the ANZICS Clinical. Trials Group. Goal ...
doi:10.1056/NEJMoa010307. ProCESS Investigators. N Engl J Med. 2014;370(18):1683-93. doi:10.1056/NEJMoa1401602. ARISE Investigators. N Engl J ...
DOI: 10.1056/NEJMoa1401602 Mouncey PR, et al. Trial of Early, Goal-Directed Resuscitation for Septic Shock. N Engl J Med 2015; 372:1301-11 ...
DOI: 10.1056/NEJMoa1401602 Mouncey PR, et al. Trial of Early, Goal-Directed Resuscitation for Septic Shock. N Engl J Med 2015; 372:1301-11 ...
4. A Randomized Trial of Protocol-Based Care for Early Septic Shock. N. 2014;370(18):1683-1693. doi:10.1056 ...
doi:10.1056/NEJMoa1401602. Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., . . . Dellinger, R. P. (2017) ...
... 10.1056/NEJMoa1401602#t=abstract. Good Stuff. 1. Birth Control for Men? https://www.bloomberg.com/news/features/2017-03-29/a-new-kind-of-male ...
DOI: 10.1056/NEJMoa1401602 Mouncey PR, et al. Trial of Early, Goal-Directed Resuscitation for Septic Shock. N Engl J Med 2015; 372:1301-11 ...
doi: 10.1056/NEJMoa1401602. Investigators TA, Group the ACT. Goal-directed resuscitation for patients with early septic shock. N Engl J ...
doi: 10.1056/NEJMoa1401602.. 4. Arise Investigators, Anzics Clinical Trials Group; Peake SL, Delaney A, Bailey. M et al.:Goal-directed ...
http://www.nejm.org/doi/full/10.1056/NEJMoa1401602. 11. The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-directed ...
Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1401602. Casserly B, Baram M, Walsh P, et al. Implementing a collaborative protocol ...
... 10.1056/NEJMoa1401602 Abstract. The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-Directed Resuscitation for Patients with ...
DOI: 10.1056/NEJMoa1401602). In ProCESS, they explore the time-honored theory in EM-resuscitation that EGDT as described by Rivers (NEJM ...
doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18. PubMed PMID: 24635773. [Full Text] [Supplement]. THE QUESTION. In patients with septic shock is ...
Full text pdf not available without subscription / abstract / doi: 10.1056/NEJMoa1401602. Editorial, Commentaries or Blogs. Lilly. The ProCESS ...
doi: 10.1056/NEJMoa1401602. Population: Adult patients >18 years old with at least 2 systemic inflammatory response syndrome (SIRS) criteria ...
org/doi/full/10.1056/NEJMoa1401602?query=fea tured_home#t=abstract 2. Craig M. Lilly. The ProCESS Trial — A New Era of Sepsis Management ...
... 10.1056/NEJMoa1401602?query=featured_home#t=abstract 2. Craig M. Lilly. The ProCESS Trial — A New Era of Sepsis Management. New Engl J Med ...
... 10.1056/NEJMoa1401602) ha confrontato tra loro tre diversi modalità ... Sempre sul New England, viene pubblicato lo studio ALBIOS (Albumin Italian ...
... 10.1056/NEJMoa1401602. http://goo.gl/Gj29iZ 搥心肝中～. Log in ... March 18, 2014DOI: 10.1056/NEJMoa1401602. http://goo.gl/Gj29iZ 搥 ...
... 10.1056/NEJMoa1401602) vorgestellt wurde, war dies allerdings nicht der Fall. Der Verzicht auf die regelmäßige Kontrolle zentralvenöser ...
2014 March 18 [doi:10.1056/NEJMoa1401602]). The three groups also did not differ significantly with regard to 90-day mortality, incidence of ...
JW
TM
C
DM
SH
CN
PP
JC
DG
JD
SL
SN
LC
HK
DM
ما
GM
DC
KM
خا
SF
CM
AC
MM
AD
BT
E
T陳
NS
AR
PV
MV
GM
SB
VS
JM